February 18, 2021
This New York Times article highlights how the pandemic significantly disrupted clinical trials, leading to the suspension or termination of thousands of studies due to safety concerns and logistical challenges. In response, many researchers adapted by implementing remote monitoring, telehealth consultations, and home delivery of medications.
Dr. Khasraw was featured and emphasized that these adaptations were not merely temporary fixes but represented a transformative shift toward more decentralized and patient-centered clinical research. He noted that the pandemic highlighted the potential for conducting clinical trials more efficiently and equitably, making participation more accessible to a broader range of patients. This approach not only enhances patient participation but also accelerates the research process, potentially leading to faster development of new treatments. Dr. Khasraw’s contributions are part of a larger effort to modernize clinical research, ensuring it is more adaptable and responsive to the needs of diverse patient populations.
Read the full article here.